CN111868229B - 一种乳酸菌及其应用 - Google Patents

一种乳酸菌及其应用 Download PDF

Info

Publication number
CN111868229B
CN111868229B CN201980007490.9A CN201980007490A CN111868229B CN 111868229 B CN111868229 B CN 111868229B CN 201980007490 A CN201980007490 A CN 201980007490A CN 111868229 B CN111868229 B CN 111868229B
Authority
CN
China
Prior art keywords
disease
preventing
lactic acid
aging
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980007490.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN111868229A (zh
Inventor
蔡英杰
黄惠宇
吴健诚
许志行
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bened Biomedical Co Ltd
Original Assignee
Bened Biomedical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bened Biomedical Co Ltd filed Critical Bened Biomedical Co Ltd
Publication of CN111868229A publication Critical patent/CN111868229A/zh
Application granted granted Critical
Publication of CN111868229B publication Critical patent/CN111868229B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201980007490.9A 2018-01-05 2019-01-04 一种乳酸菌及其应用 Active CN111868229B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862614296P 2018-01-05 2018-01-05
US62/614,296 2018-01-05
PCT/CN2019/070494 WO2019134690A1 (en) 2018-01-05 2019-01-04 A novel lactic acid bacteria and its applications

Publications (2)

Publication Number Publication Date
CN111868229A CN111868229A (zh) 2020-10-30
CN111868229B true CN111868229B (zh) 2024-06-18

Family

ID=67144146

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980007490.9A Active CN111868229B (zh) 2018-01-05 2019-01-04 一种乳酸菌及其应用

Country Status (7)

Country Link
US (1) US11938156B2 (https=)
EP (1) EP3735456B1 (https=)
JP (1) JP7309212B2 (https=)
CN (1) CN111868229B (https=)
ES (1) ES2986025T3 (https=)
TW (1) TWI705136B (https=)
WO (1) WO2019134690A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110305821B (zh) * 2019-08-28 2019-12-17 鲁东大学 副干酪乳杆菌配合car-t细胞治疗应用
JP7195714B2 (ja) * 2020-10-19 2022-12-26 曽根ファーム株式会社 炎症性腸疾患用組成物
CN110892940A (zh) 2019-11-20 2020-03-20 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56在缓解肠道炎症方面的新应用
AU2021291569A1 (en) * 2020-06-16 2022-10-20 Md Healthcare Inc. Composition for prevention or treatment of neurological or mental disorders comprising extracellular vesicles derived from lactobacillus paracasei
CN114504599A (zh) * 2020-11-16 2022-05-17 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌et-22在抗衰老、提高先天免疫方面的新应用
CN117860789A (zh) * 2020-11-16 2024-04-12 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56在抗衰老、提高先天免疫方面的新应用
KR102606636B1 (ko) * 2021-01-29 2023-11-29 주식회사 농협사료 근감소증 예방 또는 개선 효과를 갖는 바실러스 벨레젠시스 및 이의 용도
CN113322213B (zh) * 2021-07-09 2022-05-13 吉林大学 一种具有改善记忆障碍功能的副干酪乳杆菌Jlus66菌剂和应用
KR20230085279A (ko) * 2021-12-06 2023-06-14 엠테라파마 주식회사 락토바실러스 파라카제이 nk112, 실새삼 추출물 및 새삼 추출물을 포함하는 인지기능 및 장기능 장애의 예방 또는 치료용 조성물
WO2024086963A1 (en) * 2022-10-24 2024-05-02 Bened Biomedical Co., Ltd. Lactic acid bacterium and method for preventing or minimizing exercise-induced muscle damage
CN116064314B (zh) * 2022-11-01 2024-05-31 江苏省农业科学院 一株副干酪乳杆菌及其在制备发酵黑莓汁中的应用
CN116617273A (zh) * 2023-07-13 2023-08-22 微康益生菌(苏州)股份有限公司 副干酪乳杆菌lc86在制备用于预防、缓解或治疗与衰老相关的肌肉萎缩的产品中的应用
CN119950560A (zh) * 2025-03-10 2025-05-09 杭州百芮生物科技有限公司 乳酸菌菌株组合物在制备用于舒缓情绪以及促进神经元生长的组合物中的应用
CN120310715B (zh) * 2025-06-18 2025-10-24 宁波大学 一株具有改善抑郁功效的益生菌及其微生态制剂和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104673700A (zh) * 2013-11-29 2015-06-03 晨晖生物科技股份有限公司 乳酸菌株及引物组
CN106103696A (zh) * 2014-03-24 2016-11-09 大塚制药株式会社 新颖的拟干酪乳杆菌菌株
TWI592487B (zh) * 2016-10-05 2017-07-21 益福生醫股份有限公司 新穎副乾酪乳桿菌副乾酪亞種ｋ５６

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092959A (ja) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
DK2411027T3 (en) * 2009-03-25 2015-01-19 Chr Hansen As USING a probiotic ADJUSTING body weight
JP6305085B2 (ja) 2014-02-06 2018-04-04 キヤノン株式会社 Ｘ線撮影装置及びその制御方法
EP3067058A1 (en) * 2015-03-13 2016-09-14 Farmagens Health Care Srl Biological composition based on engineered lactobacillus paracasei subsp. paracasei f19 for the biosynthesis of cannabinoids
ITUB20152376A1 (it) * 2015-07-07 2017-01-09 Alfasigma Spa Lactobacillus paracasei per la produzione di acido linoleico coniugato, preparazioni nutrizionali e farmaceutiche che lo comprendono e loro uso
JP7303811B2 (ja) 2017-12-19 2023-07-05 デュポン ニュートリション バイオサイエンシーズ エーピーエス 認知的及び精神的健康のためのプロバイオティクス

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104673700A (zh) * 2013-11-29 2015-06-03 晨晖生物科技股份有限公司 乳酸菌株及引物组
CN106103696A (zh) * 2014-03-24 2016-11-09 大塚制药株式会社 新颖的拟干酪乳杆菌菌株
TWI592487B (zh) * 2016-10-05 2017-07-21 益福生醫股份有限公司 新穎副乾酪乳桿菌副乾酪亞種ｋ５６

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
a farmacogenomic and clinical update.《Nutr Hosp.》.2013,第28卷(第6期),1842-1850. *
Alessandro Di Cerbo等.Lactobacillus Paracaseisubsp. ParacaseiF19 *
Comparative sequence analysis of a recA gene fragment brings new evidence for a change in the taxonomy of the Lactobacillus casei group;Giovanna E. Felis等;《International Journal of Systematic and Evolutionary Microbiology》;第51卷;2113-2117 *
Lactobacillus paracasei PS23 Delays Progression of Age-Related Cognitive Decline in Senescence Accelerated Mouse Prone 8 (SAMP8) Mice;Shih-Yi Huang等;《Nutrients 》;第10卷;894（第1-13页） *
Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products;Meng-Chun Cheng等;《PHARMACEUTICAL BIOLOGY》;第55卷(第1期);487-496 *

Also Published As

Publication number Publication date
EP3735456C0 (en) 2024-04-10
EP3735456A4 (en) 2021-09-29
EP3735456A1 (en) 2020-11-11
JP7309212B2 (ja) 2023-07-18
US20210085731A1 (en) 2021-03-25
US11938156B2 (en) 2024-03-26
ES2986025T3 (es) 2024-11-08
EP3735456B1 (en) 2024-04-10
TW201930585A (zh) 2019-08-01
JP2021509811A (ja) 2021-04-08
WO2019134690A1 (en) 2019-07-11
CN111868229A (zh) 2020-10-30
TWI705136B (zh) 2020-09-21

Similar Documents

Publication Publication Date Title
CN111868229B (zh) 一种乳酸菌及其应用
JP7038202B2 (ja) 新規な乳酸菌およびその用途
RU2563525C2 (ru) Пробиотическая композиция для применения в лечении воспаления кишечника
CN102597214B (zh) 新型植物乳杆菌及含该植物乳杆菌的组合物
RU2734031C2 (ru) Новая лактобактерия, характеризующаяся различными функциями, и ее применение
DK2455450T3 (en) NOVEL Lactobacillus plantarum AND COMPOSITION CONTAINING THIS
RU2486234C2 (ru) ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
EP3641568B1 (en) Composition comprising bacterial strains belonging to the species lactobacillus salivarius for the treatment of parkinson's disease
CN112204129A (zh) 植物乳杆菌kbl396菌株及其用途
CN102292431A (zh) 一种新型植物乳杆菌及含该植物乳杆菌的组合物
CN111676171B (zh) 用于婴儿过度啼哭的益生菌
US12453748B2 (en) Composition for suppressing or improving eye fatigue
US11058733B2 (en) Active substances of Bifidobacterium lactis GKK2, composition comprising the same and method of promoting longevity using the same
WO2012075684A1 (zh) 乳酸菌株及其调节免疫反应的用途
KR20240038015A (ko) 신생아의 치료에서 락토바실러스 파라카세이 박테리아 균주의 용도
EP1796697B1 (en) A composition having immunoregulating activities comprising lactobacillus pentosus
CA2568014A1 (en) Lactic acid bacteria with immunoregulating activities
TWI721082B (zh) 新穎乳酸菌及其應用
Gbadamosi et al. Probiotics as Agents of Health Improvement, Infection Control and Diseases Treatment: A Review
HK40044456A (en) Lactobacillus plantarum kbl396 strain and use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant